about
Recommendations of the GARIN group for managing non-critically ill patients with diabetes or stress hyperglycaemia and artificial nutritionType 2 diabetes mellitus in relation to global LINE-1 DNA methylation in peripheral blood: a cohort study.Obesity and the metabolic syndrome in Mediterranean countries: a hypothesis related to olive oil.Comparison of the Effects of Goat Dairy and Cow Dairy Based Breakfasts on Satiety, Appetite Hormones, and Metabolic Profile.Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey.An update on probiotics, prebiotics and symbiotics in clinical nutrition.Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study).Prevalence of diabetes, prediabetes, and stress hyperglycemia: insulin therapy and metabolic control in patients on total parenteral nutrition (prospective multicenter study).[D-Lactic acidosis secondary to short bowel syndrome].Hypovitaminosis D and incidence of obesity: a prospective study.Night-time sleep duration and the incidence of obesity and type 2 diabetes. Findings from the prospective Pizarra study.Hospital discharge records under-report the prevalence of diabetes in inpatients.Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes.Oleic acid from cooking oils is associated with lower insulin resistance in the general population (Pizarra study).Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: longitudinal study.Dietary palmitic acid influences LDL-mediated lymphocyte proliferation differently to other mono- and polyunsaturated fatty acids in rats.Methylation levels of the SCD1 gene promoter and LINE-1 repeat region are associated with weight change: an intervention study.Stress hyperglycaemia in hospitalized patients with coronary artery disease and type 2 diabetes risk.[Intragastric injection of botulinum toxin. A real alternative for obesity treatment? A systematic review].[Preferences for the attributes of home enteral nutrition (HEN) in Spain. Do caregivers know their patients' preferences?]Organization and management of clinical nutrition in Spain. How do we assess the quality of our activities?Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2).Economic cost associated with type II diabetes in Spanish patients.Cost analysis of home parenteral nutrition in SpainPro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid.The Calculating Boluses on Multiple Daily Injections (CBMDI) study: A randomized controlled trial on the effect on metabolic control of adding a bolus calculator to multiple daily injections in people with type 1 diabetes.Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and[Home parenteral nutrition: a consensus document of experts from Andalucia and Extremadura].Patients' and professionals' preferences in terms of the attributes of home enteral nutrition products in Spain. A discrete choice experiment.Nutrición Hospitalaria 2016-2017: achivements and challengesVitamin D deficiency in outpatients with inflammatory bowel disease: prevalence and association with clinical-biological activityVitamin D and incidence of diabetes: A prospective cohort studyVitamin D deficiency in Spain: a population-based cohort studyOrganización de la asistencia a la transexualidad en el sistema sanitario público españolHypoglycemia in noncritically ill patients receiving total parenteral nutrition: A multicenter studyUsefulness of the daily defined dose method to estimate trends in the consumption, costs and prevalence of the use of home enteral nutrition[Costs versus benefits of oral nutritional supplements]Evidence-based recommendations and expert consensus on enteral nutrition in the adult patient with diabetes mellitus or hyperglycemiaDairy Product Consumption and Metabolic Diseases in the Di@bet.es StudyDoes the intake of nuts and seeds alter the appearance of menarche?
P50
Q26826909-93CE7E76-F337-40EE-B54C-A50B30A852D1Q36211305-E856A941-90DE-4685-9822-5368590F8427Q36959021-0E9AFB30-673D-462E-B69F-AE795D9F9305Q38623915-0737823F-2A40-4799-ABF4-DC9C1B74FD0AQ38797361-432B93AB-888D-4CB4-A463-A5CE39121EDCQ40538673-B047C08D-C6E7-4DD3-9219-06378147485CQ41466440-BDA8C91B-551E-4CC6-A981-0ACED9E30603Q42200696-0F52761E-3AA0-4B76-8BB8-3AAE644F27D6Q42749872-44FF753B-536A-4C23-B9AC-D2ADD72E49ADQ43789171-4546CDE8-62F4-42DE-B277-DE1F7D55EA48Q44188877-089FF345-6183-46C2-8642-5527DBAD530CQ44298330-A75A63F9-83B9-45D0-9985-4B2367B9CFAEQ44597952-09863E18-235A-478D-8034-EB2BCF58FD01Q44720625-1FE9FE8A-7B9E-47AB-B571-097D55D20C8DQ46040115-DAEE01C7-8285-478C-9F57-B82778594DDFQ46810005-0F6A2078-278E-4A33-B363-0F678EB57A97Q47173375-9944DB99-FE6A-4314-AC2A-4D2787C3D0B8Q47690584-44CE4D76-7650-4CA4-BFD0-192D71EAA04CQ49560810-DC800BA3-95C2-4E5A-AFFA-835AEC0D29FCQ50051844-E2583761-130A-4D0B-AD47-C78C53E184C0Q50221022-67E6EADB-382D-4F49-B4F9-4982CEC817A3Q50680507-E8A6C331-A7C5-4E43-9E04-B0A71BF4E5C5Q50785647-594A3971-11E2-413A-ABBD-9C2A8C7824FDQ51339268-59A06328-363C-4E11-8F05-2DFB4122CC60Q51491761-492A5DDC-AD3E-40E2-AE75-D3C94DB24E98Q51534425-1B00F17C-ACCD-4160-A4FF-66913D267744Q51582826-CD115C6B-A48E-4AC5-94C2-718BF52C0D96Q51790852-C67A7CB9-B9D6-4813-B6D2-6EB02094FE40Q53829628-58D520B1-296D-435B-87AA-39268A3DCA9FQ53985825-57F14CD0-4FBB-4D0D-86F0-B9D43F7555E6Q57031737-09BA3615-7F53-4DB1-9ABB-B4C4724A0523Q59326232-86BF5847-2C7E-40E7-A623-6E24579C7DA1Q59326237-0C4FA03D-E2E5-454C-8A51-834393DA6B40Q59570319-73F1C5E7-D8E2-41E3-9F8E-60259D6BB885Q60447625-6D76A8A8-D72A-46F8-9A62-0BF6F24F66B6Q60447631-7A79AA1C-7FDA-43D6-A372-8803C331F14BQ60447634-4A21AFFA-AC8A-4BC2-A484-DDF3AC60341CQ61028626-49D5B74D-888E-4F42-AB92-FCA9101B573EQ64256195-BC856DA2-385E-4ECF-B154-DF74D402AEDDQ71856721-E408ECD2-8A04-492E-AF56-3D563DC5D46D
P50
description
researcher
@en
name
G Olveira
@en
G Olveira
@nl
type
label
G Olveira
@en
G Olveira
@nl
prefLabel
G Olveira
@en
G Olveira
@nl
P106
P31
P496
0000-0002-7646-2899